Related Experiment Video
Updated: Jul 3, 2026

Isolating Interaction-Null/Impaired Mutants Using the Yeast Two-Hybrid Assay
Published on: December 29, 2023
Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach
Subhash Thalappilly1, Muhtadi Suliman, Odile Gayet
1INSERM U624, Stress Cellulaire, Marseille, France.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease that shows minimal response to chemotherapy. Genetic changes involved in the progression of PDAC concern genes that encode proteins related to signal transduction networks. This fact reveals the importance in identifying the role and the relations between multiple signaling cascades in PDAC. One of the major factors that modulate signaling events is multidomain scaffold proteins that function by binding several proteins simultaneously, inducing their proximity and influencing the outcome of signaling. A particular group among them, containing multiple Src homology 3 (SH3) domains that can bind proteins containing proline-rich motifs, was associated to different aspects of cancer cell homeostasis. In this work, using a microarray-based analysis, we have shown that 13 multiple SH3 domain containing scaffold proteins are expressed in PDAC cells. Using a yeast two-hybrid approach, we have identified proteins that interact with these adaptor proteins. Among them we have found several molecules that modulate cell proliferation and survival (CIZ1, BIRC6, RBBP6), signaling (LTBP4, Notch2, TOM1L1, STK24) and membrane dynamics (PLSCR1, DDEF2, VCP). Our results indicate that interactions mediated by multi-SH3 domain-containing proteins could lead to the formation of dynamic protein complexes that function in pancreatic cancer cell signaling. The identification of such protein complexes is of paramount importance in deciphering pancreatic cancer biology and designing novel therapeutic approaches.
Insights
Pancreatic ductal adenocarcinoma (PDAC) involves complex signaling pathways. This study identifies key scaffold proteins and their interactions, offering new therapeutic targets for this challenging cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with limited treatment options.
- Signal transduction networks are crucial in PDAC progression, making their components important therapeutic targets.
Purpose of the Study:
- To investigate the role of multidomain scaffold proteins, particularly those with multiple Src homology 3 (SH3) domains, in PDAC.
- To identify novel protein interactions and complexes involving these scaffold proteins in pancreatic cancer cells.
Main Methods:
- Microarray-based analysis to identify expressed SH3 domain-containing scaffold proteins in PDAC cells.
- Yeast two-hybrid approach to discover protein-protein interactions with these identified scaffold proteins.
Main Results:
- Thirteen multiple SH3 domain-containing scaffold proteins were found to be expressed in PDAC cells.
- Interactions were identified with proteins involved in cell proliferation (CIZ1, BIRC6, RBBP6), signaling (LTBP4, Notch2, TOM1L1, STK24), and membrane dynamics (PLSCR1, DDEF2, VCP).
Conclusions:
- Multi-SH3 domain-containing proteins mediate interactions forming dynamic complexes crucial for pancreatic cancer cell signaling.
- These identified protein complexes are vital for understanding PDAC biology and developing new therapeutic strategies.
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces

